Portion of patients with Mehran risk score greater than 6 and incidence of MAEs in the CI‐AKIsCyC group and the non‐CI‐AKIsCyC group. CI‐AKIsCyC indicates contrast‐induced acute kidney injury defined by serum cystatin C; MAEs, major adverse events. **P<0.01.
Portion of patients with Mehran risk score greater than 6 and incidence of MAEs in patients stratified by the composite of sCyC and sCr. CI‐AKI indicates contrast‐induced acute kidney injury; MAEs, major adverse events; sCr, serum creatinine; sCyC, serum cystatin C. ***P<0.001.
Cross-lagged path analysis of childhood body mass index (BMI) and insulin (n=990), adjusted for age, race, sex, and follow-up years. β1 and β2 are cross-lagged path coefficients; r1 is synchronous correlations; r2 and r3 are tracking correlations; R2 is variance explained. Goodness-of-fit: root mean square residual=0.063 and comparative fit index=0.93. Coefficients different from 0: *P<0.01, †P<0.001 for difference between β1 and β2.
Cross-lagged analysis models of childhood body mass index (BMI) and insulin in normotensive and hypertensive groups, adjusted for age, race, sex, and follow-up years. β1 and β2 are cross-lagged path coefficients; r1 is synchronous correlations; r2 and r3 are tracking correlations; R2 is variance explained. Goodness-of-fit: root mean square residual (RMR)=0.047 and comparative fit index (CFI)=0.94 for hypertensives; RMR=0.069 and CFI=0.93 for normotensives; Coefficients different from 0: *P<0.01, †P<0.001 for difference in β2s between hypertensive and normotensive groups.
